How does sibutramine work?

被引：44
|
作者：
Lean, MEJ [1 ]
机构：
[1] Univ Glasgow, Dept Human Nutr, Royal Infirm, Glasgow G31 2ER, Lanark, Scotland
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2001年 / 25卷 / Suppl 4期
关键词：
sibutramine; serotonin and noradrenaline reuptake inhibitor (SNRI); energy intake; energy expenditure; weight loss;
D O I：
10.1038/sj.ijo.0801931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sibutramine offers three types of benefit in weight management: by enhancing weight loss, by improving weight maintenance and by reducing the comorbidities of obesity. The clinical effects of sibutramine are explained through its known mode of action as a serotonin (5-HT) and noradrenaline reuptake inhibitor (SNRI). This dual mechanism of action results in two synergistic physiological effects-a reduction in energy intake and an increase in energy expenditure, which combine to promote and maintain weight loss.
引用
收藏
页码：S8 / S11
页数：4
相关论文
共 50 条
  • [1] How does sibutramine work?
    MEJ Lean
    International Journal of Obesity, 2001, 25 : S8 - S11
  • [2] When, for whom and how to use sibutramine?
    Astrup, A
    Toubro, S
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (Suppl 4) : S2 - S7
  • [3] When, for whom and how to use sibutramine
    A Astrup
    S Toubro
    International Journal of Obesity, 2001, 25 : S2 - S7
  • [4] How effective is sibutramine for the treatment of overweight adolescents?
    Yanovski, Jack A.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (02): : 82 - 83
  • [5] Sibutramine and energy balance
    Astrup, A
    Hansen, DL
    Lundsgaard, C
    Toubro, S
    INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 : S30 - S35
  • [6] Does prior authorization of sibutramine improve medication compliance or weight loss?
    Risser, JA
    Vash, PD
    Nieto, L
    OBESITY RESEARCH, 2005, 13 (01): : 86 - 92
  • [7] Morbid Obesity and Sleeve Gastrectomy: How Does It Work?
    Papailiou, Joanna
    Albanopoulos, Konstantinos
    Toutouzas, Konstantinos G.
    Tsigris, Christos
    Nikiteas, Nikolaos
    Zografos, George
    OBESITY SURGERY, 2010, 20 (10) : 1448 - 1455
  • [8] Does pharmacologically induced weight loss improve cardiovascular outcome? Sibutramine pharmacology and the cardiovascular system
    Sharma, AM
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0L) : L39 - L43
  • [9] Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women
    Sari, Ramazan
    Eray, Esin
    Ozdem, Sabahat
    Akbas, Halide
    Coban, Erkan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (03) : 179 - 184
  • [10] Sibutramine and the management of obesity
    Poston, WSC
    Foreyt, JP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 633 - 642
12345